Tech Company Financing Transactions
RDMD Funding Round
RDMD, operating out of San Francisco, secured $14 million from Spark Capital, Garuda and Lux Capital.
Transaction Overview
Company Name
Announced On
4/17/2020
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds of the financing will be used to: Expand into 20 additional rare diseases and Offer new and improved research experience and research insights to participants in each rare disease community.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
121 2nd St. 700
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
RDMD is on a mission to accelerate treatments for patients with a rare disease, affecting 1 in 10 people worldwide. Rare disease patients suffer from a lack of treatment options because a smaller patient group means fewer resources are devoted to the development of treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Onno Faber
Chief Executive Officer
Nancy Yu
VP - Engineering
Leo Vandriel
VP - Marketing
Talea Miller
VP - Product Management
Brett Chung
VP - R & D
Kristina Cotter
Browse more venture capital transactions:
Prev: 4/17/2020: Gembah venture capital transaction
Next: 4/17/2020: Learn In venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs